Baylor College of Medicine.
Blood. 2013 Aug 8;122(6):853-4. doi: 10.1182/blood-2013-06-509604.
In this issue of Blood, Linette et al report a cautionary tale—a lethal off-target toxicity following T-cell receptor (TCR) optimization to enhance affinity against a tumor-associated antigen, MAGE-A3.
在本期《Blood》中,Linette 等人报告了一个警示性的故事——一种致命的脱靶毒性,源于 T 细胞受体(TCR)的优化,以增强对肿瘤相关抗原 MAGE-A3 的亲和力。